文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

胸外科手术肋间神经阻滞镇痛效果的系统评价与Meta分析

Assessment of Intercostal Nerve Block Analgesia for Thoracic Surgery: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Netw Open · 2021-11-01
一句话结论单次注射肋间神经阻滞在胸外科术后24小时内与胸段硬膜外或椎旁阻滞临床非劣效,且阿片节约效应弱于两者,作者认为最适合TEA/PVB禁忌时使用。

该系统评价与Meta分析共纳入66项研究(5184例,平均年龄53.9岁),其中59项(3325例)进入定量分析,比较肋间神经阻滞(ICNB)与全身镇痛及胸段硬膜外镇痛(TEA)、椎旁阻滞(PVB)在胸外科术后的镇痛效果与安全性。ICNB较全身镇痛显著降低术后0-6小时及7-24小时静态与动态疼痛评分,最大阿片节约效应出现在术后48小时(-10.97 MMEs)。ICNB对TEA在术后7-24小时最差动态疼痛上非劣效(0.79分),对PVB略劣(1.29分),且MME用量高于TEA和PVB。作者认为ICNB在TEA和PVB无指征时可能最为有益。

要点

  • ICNB较全身镇痛降低术后0-6小时静态疼痛(均数差-1.40分,95%CI -1.46至-1.33)和动态疼痛(-1.66分,95%CI -1.90至-1.41)。
  • ICNB术后7-24小时最差动态疼痛对TEA非劣效(均数差0.79分,95%CI 0.28-1.29),对PVB略劣(1.29分,95%CI 1.16-1.41)。
  • ICNB阿片节约效应最大在术后48小时(较全身镇痛-10.97 MMEs,95%CI -12.92至-9.02)。
  • ICNB的MME用量高于TEA(术后48小时均数差48.31 MMEs,95%CI 36.11-60.52)和PVB(3.87 MMEs,95%CI 2.59-5.15)。
  • 作者认为,ICNB可能最适合TEA和PVB无指征的病例。

适用人群与场景

  • 接受心胸外科手术的成人患者(平均年龄53.9岁,标准差10.2岁;约59%男性、41%女性)。
  • ICNB通过单次注射、持续输注或两者联合作业,至少1组患者接受ICNB局部麻醉。

诊断标准与关键阈值

  • 术后疼痛强度采用经验证的10分制量表测量最差静态或动态疼痛(0为无痛,10为剧痛)。
  • 临床相关镇痛定义为任一预设时间间隔内疼痛强度评分差值≥1分。
  • 预设观察间隔为0-6小时、7-24小时、25-48小时、49-72小时和>72小时。

研究设计与关键结果

  • 系统评价与Meta分析,共筛选694条记录,排除608条,评估86篇全文后排除20篇,最终纳入66项研究(5184例)进行定性分析,59项研究(3325例)提供至少1项结局数据进入定量Meta分析。
  • 实验性研究在分配隐藏、参与者和人员盲法、结局评估者盲法等多个领域存在高偏倚风险;研究设计与实施存在显著差异(如交叉研究、干预时机[术中vs术后]、盲法、对照组类型)。
  • ICNB vs 全身镇痛:术后0-6小时静态疼痛均数差-1.40分(95%CI -1.46至-1.33),7-24小时静态疼痛均数差-1.27分(95%CI -1.40至-1.13);0-6小时动态疼痛均数差-1.66分(95%CI -1.90至-1.41),7-24小时动态疼痛均数差-1.43分(95%CI -1.70至-1.17)。
  • ICNB对TEA:术后7-24小时最差动态疼痛均数差0.79分(95%CI 0.28-1.29),为非劣效。
  • ICNB对PVB:术后7-24小时最差动态疼痛均数差1.29分(95%CI 1.16-1.41),略劣。
  • 阿片节约效应:ICNB vs 全身镇痛最大效应在术后48小时(均数差-10.97 MMEs,95%CI -12.92至-9.02);ICNB的MME用量高于TEA(术后48小时均数差48.31 MMEs,95%CI 36.11-60.52)和PVB(术后48小时均数差3.87 MMEs,95%CI 2.59-5.15)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,遵循PRISMA报告规范,采用固定效应模型。
  • 局限:实验性研究在分配隐藏、参与者和人员盲法、结局评估者盲法等多个领域存在高偏倚风险;研究设计与实施存在显著差异(如交叉研究、干预时机[术中vs术后]、盲法、对照组类型)。

对床旁实践的改变

  • 作者认为,单次注射ICNB与胸外科术后24小时内疼痛减轻相关,且在临床上对TEA或PVB非劣效。
  • 作者认为,ICNB具有阿片节约效应,但TEA和PVB与更大的术后MME降低相关,提示ICNB可能最适合TEA和PVB无指征的病例。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The use of intercostal nerve block (ICNB) analgesia with local anesthesia is common in thoracic surgery. However, the benefits and safety of ICNB among adult patients undergoing surgery is unknown.

OBJECTIVE: To evaluate the analgesic benefits and safety of ICNB among adults undergoing thoracic surgery.

DATA SOURCES: A systematic search was performed in Ovid MEDLINE, Ovid Embase, Scopus, and the Cochrane Library databases using terms for ICNB and thoracic surgery (including thoracic surgery, thoracoscopy, thoracotomy, nerve block, intercostal nerves). The search and results were not limited by date, with the last search conducted on July 24, 2020.

STUDY SELECTION: Selected studies were experimental or observational and included adult patients undergoing cardiothoracic surgery in which ICNB was administered with local anesthesia via single injection, continuous infusion, or a combination of both techniques in at least 1 group of patients. For comparison with ICNB, studies that examined systemic analgesia and different forms of regional analgesia (such as thoracic epidural analgesia [TEA], paravertebral block [PVB], and other techniques) were included. These criteria were applied independently by 2 authors, and discrepancies were resolved by consensus. A total of 694 records were selected for screening.

DATA EXTRACTION AND SYNTHESIS: This study followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. Data including patient characteristics, type of surgery, intervention analgesia, comparison analgesia, and primary and secondary outcomes were extracted independently by 3 authors. Synthesis was performed using a fixed-effects model.

MAIN OUTCOMES AND MEASURES: The coprimary outcomes were postoperative pain intensity (measured as the worst static or dynamic pain using a validated 10-point scale, with 0 indicating no pain and 10 indicating severe pain) and opioid consumption (measured in morphine milligram equivalents [MMEs]) at prespecified intervals (0-6 hours, 7-24 hours, 25-48 hours, 49-72 hours, and >72 hours). Clinically relevant analgesia was defined as a 1-point or greater difference in pain intensity score at any interval. Secondary outcomes included 30-day postoperative complications and pulmonary function.

RESULTS: Of 694 records screened, 608 were excluded based on prespecified exclusion criteria. The remaining 86 full-text articles were assessed for eligibility, and 20 of those articles were excluded. All of the 66 remaining studies (5184 patients; mean [SD] age, 53.9 [10.2] years; approximately 59% men and 41% women) were included in the qualitative analysis, and 59 studies (3325 patients) that provided data for at least 1 outcome were included in the quantitative meta-analysis. Experimental studies had a high risk of bias in multiple domains, including allocation concealment, blinding of participants and personnel, and blinding of outcome assessors. Marked differences (eg, crossover studies, timing of the intervention [intraoperative vs postoperative], blinding, and type of control group) were observed in the design and implementation of studies. The use of ICNB vs systemic analgesia was associated with lower static pain (0-6 hours after surgery: mean score difference, -1.40 points [95% CI, -1.46 to -1.33 points]; 7-24 hours after surgery: mean score difference, -1.27 points [95% CI, -1.40 to -1.13 points]) and lower dynamic pain (0-6 hours after surgery: mean score difference, -1.66 points [95% CI, -1.90 to -1.41 points]; 7-24 hours after surgery: mean score difference, -1.43 points [95% CI, -1.70 to -1.17 points]). Intercostal nerve block analgesia was noninferior to TEA (mean score difference in worst dynamic panic at 7-24 hours after surgery: 0.79 points; 95% CI, 0.28-1.29 points) and marginally inferior to PVB (mean score difference in worst dynamic pain at 7-24 hours after surgery: 1.29 points; 95% CI, 1.16 to 1.41 points). The largest opioid-sparing effect of ICNB vs systemic analgesia occurred at 48 hours after surgery (mean difference, -10.97 MMEs; 95% CI, -12.92 to -9.02 MMEs). The use of ICNB was associated with higher MME values compared with TEA (eg, 48 hours after surgery: mean difference, 48.31 MMEs; 95% CI, 36.11-60.52 MMEs) and PVB (eg, 48 hours after surgery: mean difference, 3.87 MMEs; 95% CI, 2.59-5.15 MMEs).

CONCLUSIONS AND RELEVANCE: In this study, single-injection ICNB was associated with a reduction in pain during the first 24 hours after thoracic surgery and was clinically noninferior to TEA or PVB. Intercostal nerve block analgesia had opioid-sparing effects; however, TEA and PVB were associated with larger decreases in postoperative MMEs, suggesting that ICNB may be most beneficial for cases in which TEA and PVB are not indicated.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Guerra-Londono CE, Privorotskiy A, Cozowicz C, et al. Assessment of Intercostal Nerve Block Analgesia for Thoracic Surgery: A Systematic Review and Meta-analysis. JAMA Netw Open. 2021. PMID: 34779845. doi:10.1001/jamanetworkopen.2021.33394

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。